Bionomics: ASX Spotlight Series (New York, Mar 2015)

Company Presentations

by Carolyn Herbert

Bionomics Limited (ASX:BNO) CEO & Managing Director Dr Deborah Rathjen presents at ASX Spotlight Series in New York. 
The biopharmaceutical company’s presentation is titled, “Global leader in drug discovery and development”.
Ms Rathjen discusses Bionomics’ value proposition, partnered programs and in-house development programs. 
Discussing the company’s value proposition Ms Rathjen says, “We have a very broad and deep pipeline which I will walk through as I go through this presentation. 
And, this pipeline provides us with multiple opportunities for development and also for strategic partnering. 
We have a very strong cash position. 31 December cash was just over $38 million and this leaves us in a position to be able to support in a rapid and unencumbered way the development of our programs.”

Carolyn Herbert

Finance News Network
Carolyn joined FNN in August 2015 as the Head of News and also presented the Market at Midday and the Market Wrap. With more than five years of broadcast journalism experience, Carolyn has worked as a finance anchor on the Sky News Business channel and as an anchor and reporter for ABC News. She is also a qualified corporate lawyer specialising in IPOs, takeovers and mergers and acquisitions.